NCT05840263 |
Couple-Based Mindfulness Intervention for Metastatic Colorectal Cancer |
NCT03546686 |
Peri-Operative Immune Checkpoint Inhibition and Cryoablation in Women with Triple-negative Breast Cancer |
NCT04706663 |
Precision-Based Genomics in Prostate Cancer |
NCT06014086 |
Intratumoral PH-762 for Cutaneous Carcinoma |
NCT06940739 |
A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel |
NCT02189486 |
Prostate Cancer Upgrading Reference Set |
NCT06115486 |
EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer |
NCT04792463 |
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome |
NCT06774963 |
A Phase 1 Study of LNCB74 in Advanced Solid Tumors |
NCT06610539 |
PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients |
NCT06300463 |
Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases |
NCT06059963 |
A Prospective, Multi-center, Observational Study for Signal-C Test Evaluation |
NCT06654622 |
Exosome-based Detection of Molecular Residual Disease in Stage II-III Colorectal Cancer |
NCT06626022 |
Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging. |
NCT04789486 |
Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer |
NCT06037863 |
Evaluation of the Impact of Empty Versus Full Bladder in Patients with Prostate Cancer, RELIEF Trial |
NCT06820463 |
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer |
NCT05539430 |
Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic Adenocarcinoma |
NCT05810025 |
FHIR-Enhanced RealRisks to Improve Accuracy of Breast Cancer Risk Assessments |
NCT06492122 |
Study With [225Ac]Ac-FL-020 in mCRPC Participants |
NCT01915225 |
Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer |
NCT06297525 |
Study of STP938 in Advanced Solid Tumours |
NCT06805825 |
A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit |
NCT06630325 |
A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer |
NCT06307548 |
Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal Cancer |
NCT05968157 |
MIRAI-MRI: Comparing Screening MRI for Patients at High Risk for Breast Cancer Identified by Mirai and Tyrer-Cuzick |
NCT06806930 |
Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT) |
NCT04084730 |
Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer |
NCT06119425 |
Blood-Based Colorectal Cancer (CRC) Screening Implementation Into Clinical Practice Highlands |
NCT03524430 |
RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy |
NCT04588025 |
Disposable Perfusion Phantom for Accurate DCE (Dynamic Contrast Enhanced)-MRI Measurement of Pancreatic Cancer Therapy Response |
NCT02960022 |
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study |
NCT06030622 |
Phase 2A Pilot C3 Trial of Recurrent/Refractory Metastatic Advanced Pancreatic Cancer |
NCT04263025 |
AMNIOX CORD Study - Radical Prostatectomy With and Without Cryopreserved Umbilical Cord Allograft |
NCT06129422 |
Safety, Tolerability, Pharmacokinetics, Radiation Dosimetry, and PET Imaging Properties of 89Zr-labeled hNd2 (NMK89) in Patients With Pancreatic Cancer |
NCT06384222 |
Hyperpolarized (HP) 13C Pyruvate Magnetic Resonance Imaging (MRI) for Response Monitoring to Neoadjuvant Abiraterone |
NCT06028022 |
Reishi Mushroom Extract for Fatigue and/or Arthralgias/Myalgias in Patients With Breast Cancer on Aromatase Inhibitors |
NCT06657222 |
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors |
NCT04734730 |
Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer |
NCT05928325 |
Geriatric Care Survivorship Intervention for Improving the Overall Health of Older Adults With Stage I-III Breast Cancer Who Have Completed Curative Treatment |
NCT04346225 |
Magnetic Resonance Imaging (MRI) With Hyperpolarized Pyruvate (13C) as Diagnostic Tool in Advanced Prostate Cancer |
NCT05412225 |
A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer |
NCT06044857 |
PSMA PET Response Guided SabR in High Risk Pca |
NCT04678648 |
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies |
NCT06065748 |
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer) |
NCT06056830 |
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy |
NCT05256225 |
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma |
NCT04039230 |
Study to Evaluate Sacituzumab Govitecan in Combination With Talazoparib in Patients With Metastatic Breast Cancer. |
NCT03203525 |
Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic Cancer |
NCT04606030 |
LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge) |
NCT03678025 |
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer |
NCT05877430 |
Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer |
NCT05464030 |
Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01) |
NCT06610825 |
Castrate Resistant Prostate Cancer Enhertu Therapy |
NCT06161025 |
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer |
NCT03863457 |
[18F] F-GLN by PET/CT in Breast Cancer |
NCT05948657 |
Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr |
NCT06710548 |
REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors |
NCT06483048 |
MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer |
NCT01042548 |
Proteomics and Radiomics Research of Breast Cancer Markers in Tissue, Interstitial Fluid and Serum |
NCT06336148 |
A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors |
NCT06605430 |
Medical Cannabis in Patients With Advanced Pancreatic Cancer |
NCT05128825 |
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer |
NCT05051722 |
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer |
NCT05553522 |
Tucatinib, Trastuzumab, and Capecitabine With SRS for Brain Metastases From HER-2 Positive Breast Cancer |
NCT06040125 |
Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE Trial |
NCT06044025 |
A Feasibility Study Evaluating a Role for Maintenance Therapy in Patients With Biochemically Progressive Castration Sensitive Prostate Cancer on Intermittent Androgen Deprivation Therapy |
NCT06748222 |
E-Mindfulness Approaches for Living After Breast Cancer |
NCT04430725 |
Microwave Ablation or Wedge Resection for the Treatment of Lung, Sarcoma and Colorectal Lesions, ALLUME Study |
NCT06128525 |
Prostate Resection After Microwave Ablation (PRAMA) |
NCT04797039 |
MRI-Guided Cryoablation for Focal Native Prostate Cancer |
NCT04721886 |
Contrast-Enhanced Ultrasound Scan for the Estimation of Tissue Pressure in Patients With Breast Cancer |
NCT06788886 |
Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases |
NCT06246786 |
Breast/Cyclosporin A/TNBC (Triple Negative Breast Cancer) |
NCT05496686 |
Targeted Alpha Particle Radiotherapy for Metastatic Uveal Melanoma |
NCT04485286 |
Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury |
NCT06449222 |
Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy |
NCT06388122 |
DiviTum®TKa: A Biomarker Assay for Efficacy in HR+ Metastatic Breast Cancer Patients |
NCT06342986 |
Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer |
NCT06294886 |
Vaginal Fluid Collection for Detection of Endometrial Cancer |
NCT06193486 |
Autologous Gamma Delta T Cells to Target Prostate Stem Cell Antigen in mCRPC |
NCT06055439 |
A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy |
NCT04234386 |
GammaPod Dose Escalation Radiation for Early Stage Breast Cancer |
NCT06389786 |
Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate Cancer |
NCT05652686 |
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study) |
NCT04511039 |
Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer |
NCT05174286 |
Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher Risk |
NCT05894239 |
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer |
NCT03589339 |
NBTXR3 Activated by Radiotherapy for Patients with Advanced Cancers Treated with an Anti-PD-1 Therapy |
NCT06236139 |
Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer |
NCT04918186 |
Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer |
NCT04871139 |
An Imaging Technology, Contrast-Enhanced Mammography, in Predicting Breast Cancer |
NCT06398639 |
Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer |
NCT06666439 |
Longitudinal Tumor Burden Quantification Using Circulating Tumor DNA in Metastatic Lobular Breast Cancer |
NCT05768139 |
First-in-Human Study of STX-478 as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors |
NCT05226663 |
A Radiotracer ([18F]FluorThanatrace) by PET/CT for the Imaging of Breast Cancer |
NCT04115163 |
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer |
NCT05628363 |
Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With High-risk and Unfavorable Intermediate-risk Prostate Cancer |
NCT05438563 |
MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Intermediate Grade Prostate Cancer |
NCT03620786 |
HIFU for Focal Ablation of Prostate Tissue: An Observational Study |
NCT04914663 |
All-extremity Exercise During Breast Cancer Chemotherapy |
NCT06287463 |
Study of DCC-3084 in Participants With Advanced Malignancies Driven by the Mitogen-Activated Protein Kinase (MAPK) Pathway |
NCT06423963 |
Remote Exercise and Nutritional Prehabilitation for Pancreatic Cancer |
NCT02896335 |
Palbociclib and Pembrolizumab In Central Nervous System Metastases |
NCT05428735 |
The DRAGON 2 Trial |
NCT02476786 |
Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score |
NCT06400563 |
MRg-NIRS Imaging System Breast Cancer Trial |
NCT04575935 |
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial |
NCT04188535 |
Serial MRI Scans During Radiation Therapy |
NCT06778863 |
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation |
NCT04158635 |
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer |
NCT03987386 |
Conventional or Hypofractionated Radiation Therapy in Treating Patients With Prostate Cancer |
NCT05832086 |
Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes |
NCT05336786 |
Prostate Cancer Diagnosis by Multiparametric Ultrasound (Wholemount) |
NCT04633239 |
Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer |
NCT06324357 |
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread |
NCT05400122 |
Natural Killer (NK) Cells in Combination with Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer |
NCT06518057 |
Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer |
NCT06479239 |
Study of EGFRBi Armed Fresh PBMC in Metastatic or Unresectable Pancreatic Cancer |
NCT05900986 |
LS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast Cancer |
NCT06870539 |
Feasibility of Saliva and Remote Monitoring of Active Cytomegalovirus (CMV) Infection and Symptoms During Ovarian Cancer Treatment |
NCT06262139 |
Evaluation of a Targeted Magnetic Resonance Imaging Contrast Agent in Prostate Cancer Patients |
NCT06353386 |
Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A) |
NCT06158139 |
Autologous CAR-T Cells Targeting B7-H3 in PDAC |
NCT06662786 |
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer |
NCT05501886 |
Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1) |
NCT06100263 |
Breast Cancer Resiliency Through Exercise Program (B-REP) |
NCT06192758 |
Dose Escalation Study Evaluating Safety of TheraSphere Prostate Cancer (PCa) Device |
NCT05754658 |
African Cancer Genome: GMD |
NCT03526835 |
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors |
NCT06756035 |
CT-95 in Advanced Cancers Associated With Mesothelin Expression |
NCT06662435 |
GYNecologic Cancer-Related COGnitive Impairment |
NCT04887935 |
Neoadjuvant SGLT2 Inhibition in High-Risk Localized Prostate Cancer |
NCT05455658 |
STEMVAC in Patients With Early Stage Triple Negative Breast Cancer |
NCT06132958 |
Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005) |
NCT02743858 |
Lymphedema Surveillance Study |
NCT06915025 |
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer |
NCT05231122 |
Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer |
NCT03677739 |
Young Melanoma Family Facebook Intervention or Healthy Lifestyle Facebook Intervention in Improving Skin Examination in Participants With Melanoma and Their Families |
NCT06022822 |
Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy, URO-PRO Trial |
NCT05478239 |
ArtemiCoffee in Patients With Rising PSA |
NCT05896839 |
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer |
NCT03129139 |
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors |
NCT02610439 |
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer |
NCT06103669 |
Locally AblatiVe TherApy in OLigO-pRogressive SOlid TUmorS (VALOROUS) |
NCT02526368 |
Pilot Study of (MR) Imaging with Pyruvate (13C) to Detect High Grade Prostate Cancer |
NCT05789069 |
A Study of HFB200603 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors |
NCT06001268 |
Support Through Remote Observation and Nutrition Guidance Program (STRONG-PCS) |
NCT05498272 |
Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene Alterations |
NCT05396872 |
Patient Decision-making About Precision Oncology in Veterans With Advanced Prostate Cancer |
NCT05607004 |
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer |
NCT06915168 |
CIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patients With Breast Cancer |
NCT06171269 |
Using MRI to Identify Areas to Receive Lower Doses of Radiation Treatment in Men With Prostate Cancerdose Mapping to Preserve Quality of Life |
NCT05838768 |
Study of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency. |
NCT05868668 |
Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain |
NCT06663072 |
Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors |
NCT04868604 |
64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE) |
NCT02279004 |
A Prospective Study of Plasma Genotyping as a Noninvasive Biomarker for Genotype-directed Cancer Care |
NCT04854304 |
Abbreviate or FAST Breast MRI for Supplemental Breast Cancer Screening for Black Women at Average Risk and Dense Breasts |
NCT02977468 |
Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer |
NCT05490472 |
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors |
NCT02863172 |
Molecular Basis for Variations in Hereditary Colorectal Cancer Syndromes |
NCT04044872 |
Hyperpolarized Carbon 13-Based Metabolic Imaging to Detect Radiation-Induced Cardiotoxicity |
NCT07047872 |
A 3D-Printed External Breast Prosthesis for the Improvement of Patient-reported Outcomes Among Breast Cancer Patients That Underwent a Mastectomy Without Reconstruction |
NCT05929768 |
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer |
NCT05649072 |
Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics. |
NCT05712668 |
Telemedicine Use in Preoperative Counseling for Endometrial Cancer Survivors |
NCT01950572 |
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma |
NCT06500169 |
Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors |
NCT03611868 |
A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors |
NCT06371768 |
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors |
NCT06835569 |
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations |
NCT04589468 |
Researching the Effect of Exercise on Cancer |
NCT04994067 |
Intra-Operative Radiation Registry |
NCT06824467 |
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103) |
NCT04599140 |
SX-682 and Nivolumab for the Treatment of RAS-Mutated, MSS Unresectable or Metastatic Colorectal Cancer, the STOPTRAFFIC-1 Trial |
NCT02628067 |
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) |
NCT05218044 |
Cryoablation as a Minimally Invasive Alternative to Surgery for Managing Ductal Carcinoma In Situ |
NCT05795101 |
TRUDI: TDXD+Durva in HER2+/low IBC |
NCT04474301 |
Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic |
NCT05417867 |
Evaluating the Association Between Changes in the Gut Microbiome, Fatigue, and Chemotherapy-Induced Nausea in Early Stage Breast Cancer |
NCT06589440 |
Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC) |
NCT05367440 |
Study of AZD5305 When Given in Combination With New Hormonal Agents in Patients With Metastatic Prostate Cancer |
NCT05023967 |
Metformin and Nightly Fasting in Women With Early Breast Cancer |
NCT06046040 |
TmPSMA-02 in mCRPC |
NCT06388967 |
Pancreatic Cancer Detection Consortium |
NCT04783467 |
Time Restricted Eating (TRE) Among Endometrial Cancer Patients |
NCT05554367 |
Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial |
NCT06342440 |
Early Detection of Advanced Adenomas and Colorectal Cancer |
NCT05059444 |
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation |
NCT06764940 |
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients with Brain Metastases |
NCT04879940 |
Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization |
NCT06083844 |
Phase II Investigation of Pembrolizumab in Combination With Bevacizumab and Oral Cyclophosphamide in Patients With High Grade Ovarian Cancer and Surgically Documented Minimal Residual Disease After Frontline Therapy |
NCT06392789 |
A Conversational Agent (Cecebot) to Improve Insomnia in Stage I-III Breast Cancer Survivors |
NCT01954992 |
Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer |
NCT05472792 |
Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy |
NCT04031469 |
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease |
NCT06562192 |
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers |
NCT06095089 |
A Study of JNJ-87189401 Plus JNJ-78278343 for Advanced Prostate Cancer |
NCT06092892 |
IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients with Breast Cancer with Nodal Metastases |
NCT05691504 |
Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers |
NCT05415072 |
A Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas |
NCT04265872 |
Bortezomib Followed by Pembrolizumab and Cisplatin in metTNBC |
NCT04739072 |
Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study |
NCT06182072 |
ProAgio in Pancreatic Ductal Adenocarcinoma (PDAC) |
NCT03270072 |
The Differential Impact of Proton Beam Irradiation Versus Conventional Radiation on Organs-at-risk in Stage II-III Breast Cancer Patients |
NCT06400472 |
A Study of LY4170156 in Participants With Selected Advanced Solid Tumors |
NCT05132504 |
Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer |
NCT06418204 |
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics |
NCT06789172 |
A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors |
NCT06545604 |
Comprehensive Yoga Therapy Based Lifestyle Prehabilitation Program for Women With Ovarian Cancer |
NCT06877572 |
Weight Loss Management in Endometrial Cancer Survivors |
NCT06728072 |
Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer |
NCT06086704 |
Study of 18F-FFNP Breast PET/MRI |
NCT06993844 |
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors |
NCT03606967 |
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer |
NCT03564340 |
Study of REGN4018 Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers |
NCT06361940 |
Molecular Analyses to Predict Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients with Hormone Receptor-Positive HER2-negative Breast Cancer |
NCT05372640 |
Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors |
NCT05130840 |
Monitoring for Cancer Spread to the Central Nervous System (CNS) in People With Breast Cancer |
NCT05537740 |
A First-in-human Study to Learn How Safe the Study Drug BAY3375968, an Anti-CCR8 Antibody, is, When Given Alone or in Combination With Pembrolizumab, How it Affects the Body, How it Moves Into, Through, and Out of the Body, and to Find the Best Dose in Participants With Advanced Solid Tumors |
NCT04475640 |
Cancer Genetic Testing in Ethnic Populations |
NCT05242744 |
FTT PET/CT in Metastatic Prostate Cancer |
NCT05130801 |
A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery |
NCT06697301 |
Safety and Efficacy of EIK1001-006 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma. |
NCT05837767 |
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue |
NCT05112601 |
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma |
NCT04674267 |
Resilience and Equity in Aging, Cancer, and Health (REACH) |
NCT02772367 |
Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients |
NCT06239467 |
First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer |
NCT05464667 |
Preoperative Irradiation for Stage I Breast Cancer |
NCT05736367 |
Investigating the Metabolic Pathways in Hormone Receptor Positive/HER2 Negative Breast Cancer |
NCT05705401 |
Testing Radiation and HER2-targeted Therapy Versus HER2-targeted Therapy Alone for Low-risk HER2-positive Breast Cancer |
NCT01834001 |
Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy |
NCT06710067 |
Urine Metabolites in the Diagnosis of Disease |
NCT05355701 |
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations. |
NCT03228667 |
QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors |
NCT06643767 |
Evaluation of the Bexa Breast Examination |
NCT05039801 |
IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors |
NCT05155501 |
Clinical Trial of Approaches to Prostate Cancer Surgery |
NCT04580667 |
Prospective Observational Exploratory Clinical Study to Determine the Assay Cut-Off for the RadTox Test in Prostate Cancer Patients to Predict Gastrointestinal Radiation Toxicity Using Circulating Cell Free DNA Directly From Plasma |
NCT04314401 |
National Cancer Institute "Cancer Moonshot Biobank" |
NCT04349501 |
Biomarker Monitoring of Prostate Cancer Patients With RSI MRI (ProsRSI) |
NCT02701244 |
A Registry Study of Breast Microseed Treatment |
NCT04956640 |
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C) |
NCT03671044 |
A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients |
NCT02870244 |
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes |
NCT02402244 |
Project: Every Child for Younger Patients With Cancer |
NCT04731844 |
Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer |
NCT04787744 |
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer |
NCT06666192 |
The Ohio State University (OSU) SCREEN Community Program |
NCT06771544 |
Metronomic Cyclophosphamide With Pembrolizumab in Checkpoint Inhibitor Refractory Melanoma |
NCT03919292 |
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca |
NCT06295744 |
Outcomes and Cosmesis With Whole Breast Irradiation and Boost |
NCT05458674 |
Tucatinib+Trastuzumab+Eribulin in HER2+ MBC |
NCT05361174 |
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer |
NCT03452774 |
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry |
NCT04756765 |
Talazoparib Monotherapy in PALB2 Mutation Associated Advanced Breast Cancer |
NCT06904365 |
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women |
NCT06268665 |
Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy |
NCT05983276 |
Decitabine and Selinexor in Combination to Reverse Drug Resistance With Standard Chemotherapy in Ovarian Cancer |
NCT05485974 |
A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation |
NCT06799065 |
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer |
NCT06660420 |
Phase 1 Dose Escalation and Expansion Study of PRAME T Cell Receptor (TCR) Engineered NK Cells in Participants With Recurrent and/or Refractory Melanoma (PRAMETIME-Mel) |
NCT06376565 |
Improving Colonoscopy Surveillance for Patients with High Risk Colon Polyps |
NCT02749474 |
Maternal Cancer Diagnosis and Treatment During Pregnancy:a Database for Maternal, Fetal, and Neonatal Outcomes |
NCT04449874 |
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation |
NCT06297265 |
Manual Lymphatic Drainage Breast Massage in Breast Cancer Patients After Breast Conserving Surgery |
NCT05563220 |
Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Patients With Metastatic Breast Cancer |
NCT05764720 |
Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach |
NCT04959474 |
Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer |
NCT05933265 |
Study of LP-184 in Patients With Advanced Solid Tumors |
NCT02207465 |
A Phase I Dual Dose Escalation Study of Radiation and Nab-Paclitaxel in Patients With Unresectable and Borderline Resectable Pancreatic Cancer |
NCT03090165 |
Ribociclib and Bicalutamide in AR+ TNBC |
NCT06721065 |
A Study of Language Interpretation Solutions for People With Breast Cancer |
NCT05691465 |
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells |
NCT04771520 |
Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors |
NCT05931874 |
Optimizing a mHealth Physical Activity Intervention With Mindful Awareness Lessons in Breast Cancer Survivors |
NCT03572374 |
Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job |
NCT06413680 |
A First-In Human (FIH) Trial to Find Out if REGN10597 is Safe and How Well it Works for Adult Participants With Advanced Solid Organ Malignancies |
NCT06264180 |
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs (IGNYTE-3) |
NCT05272462 |
Oral Minoxidil for the Treatment of Recurrent Platinum Resistant Epithelial Ovarian Cancer |
NCT06188520 |
A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors |
NCT06639074 |
Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial |
NCT04339374 |
Ultrasound and Photoacoustic Imaging for Enhanced Differential Diagnosis of Rectal Cancer |
NCT06340620 |
EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope |
NCT06253520 |
Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer |
NCT05115474 |
Study of Screening Brain MRIs in Stage IV Breast Cancer |
NCT04510129 |
A Multicenter Cancer Biospecimen Collection Study |
NCT06708429 |
Lynch Syndrome X-Talk of Enteral Mucosa With Immune System |
NCT05965180 |
Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic Probe |
NCT05077280 |
A Study of Concurrent Stereotactic Body Radiotherapy With Opdualag in Metastatic Uveal Melanoma |
NCT05754580 |
High-dose Brachytherapy Boost With Stereostatic Body Radiation Therapy to Intermediate or Higher Risk Prostate Cancer |
NCT05620329 |
UNC Pleural Fluid Registry |
NCT04919629 |
APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant Effusion |
NCT06485089 |
Effects of Tirzepatide on Blood, Imaging and Breast Tissue Biomarkers |
NCT06751589 |
A Study of a Weight Loss Intervention in People With Endometrial Cancer |
NCT06022029 |
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. |
NCT05984589 |
Personalized Health Self-Management Training for Colorectal Cancer Survivors |
NCT03151629 |
International Registry for Men With Advanced Prostate Cancer (IRONMAN) |
NCT05316129 |
Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer |
NCT05440929 |
Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians |
NCT06194929 |
Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma |
NCT05645380 |
Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC |
NCT06085729 |
Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC) |
NCT05919329 |
Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy |
NCT05710380 |
MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy |
NCT04134780 |
Ultrasound Imaging and Spectroscopy as Early Indicators of Locally-Advanced Breast Cancer Response |
NCT04748380 |
Shared Decision-making and Colorectal Cancer Screening |
NCT06574880 |
STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate Cancer |
NCT05625529 |
ExoLuminate Study for Early Detection of Pancreatic Cancer |
NCT04337580 |
Fatty Acid Synthase Inhibition in Castration Refractory Prostate Cancer |
NCT05785780 |
Aim 3, Optimizing CRC Screening in Patients With Diabetes in Safety-net Primary Care Settings |
NCT06651580 |
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study |
NCT04258280 |
Improving Genetic Counseling for BRCA+ Mothers |
NCT04329065 |
Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer |
NCT05020574 |
Microbiome and Association With Implant Infections |
NCT03538665 |
The DETECT Study: Discovery and Evaluation of Testing for Endometrial and Ovarian Cancer in Tampons |
NCT06549465 |
Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan in Participants With PSMA PET-Positive Castration-Resistant Prostate Cancer (CRPC) |
NCT04812366 |
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer |
NCT03048266 |
Metabolomics and Genetic Diagnosing Pancreatic Neuroendocrine Tumors in MEN1 Patients |
NCT06488365 |
In Vivo Liquid Biopsy of Melanoma (Cytophone) |
NCT06378866 |
Stereotactic Body Radiation Therapy Plus Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy for Treatment of Metastatic, Recurrent Hormone-Sensitive Prostate Cancer, DIVINE Trial |
NCT06610474 |
Evaluation of an Online Prostate Cancer Screening Decision Aid |
NCT05327465 |
Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy |
NCT00756665 |
Prostate Active Surveillance Study |
NCT05268666 |
A Study of Orally Administered JBI-802, an LSD1/HDAC6 Inhibitor, in Patients With Advanced Solid Tumors |
NCT05289466 |
Oncoplastic Partial Mastectomy With Intraoperative Radiation Therapy (IORT) in Early Stage Breast Cancer Patients With Prior History of Chest Wall Radiation. |
NCT04198766 |
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist) |
NCT04503265 |
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies |
NCT05579366 |
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) |
NCT06090266 |
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents |
NCT03769766 |
Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance |
NCT05941520 |
Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer |
NCT05679674 |
Stereotactic Body Radiation and Tumor Treating Fields for Locally Advanced Pancreas Cancer |
NCT04662580 |
ARX517/JNJ-95298177 as Monotherapy or Combination Therapy in Subjects With Metastatic Prostate Cancer |
NCT06538389 |
High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer |
NCT05544929 |
A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers |
NCT05496829 |
IMPACT Trial: Intervention to iMProve AdherenCe Equitably |
NCT05983380 |
The Effect of Hand Exercises on Upper Limb Volume, Quality of Life, and Hand Function in Breast Cancer Survivors |
NCT06245889 |
PET Dynamics to Response-Adapted Neoadjuvant Therapy in TNBC |
NCT02478892 |
Preliminary Evaluation of Screening for Pancreatic Cancer in Patients with Inherited Genetic Risk |
NCT06614192 |
A Randomized Trial Assessing Adverse Events and Disease Activity When Comparing Intravenously (IV) Infused ABBV-400 to Trifluridine and Tipiracil (LONSURF) Oral Tablets Plus IV Infused Bevacizumab in Adult Participants With c-Met Over-Expressed Refractory Metastatic Colorectal Cancer |
NCT06478589 |
Patient Priorities for Survivorship Care in Older Breast Cancer Survivors |
NCT05143229 |
Alpelisib And Sacituzumab Govitecan For Treatment Of Breast Cancer |
NCT04840589 |
Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid Tumors |
NCT01441089 |
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis |
NCT02926729 |
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy |
NCT03692429 |
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells |
NCT04562129 |
IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients |
NCT04512144 |
Mindfulness in Endometrial and Cervical Cancer |
NCT05819892 |
Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer |
NCT06673329 |
Brodalumab in the Treatment of Immune-Related Adverse Events |
NCT04423029 |
A Study of DF6002 Alone and in Combination With Nivolumab |
NCT06751329 |
A Study of DM002 in Patients With Advanced Solid Tumors |
NCT06435429 |
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer |
NCT05726292 |
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer |
NCT04609592 |
Study of PRRT in Metastatic, World Health Organization (WHO) Grade 1 or 2, SSTR Positive, GEP-NET Who Are Candidates for Cytoreductive Surgery |
NCT06965192 |
Designing Visual Tools to Enhance Cancer Surgeon Decision-making |
NCT06218303 |
Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ |
NCT03384238 |
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery |
NCT06388304 |
THRIVE Study: Positive Affect Training for Endocrine Therapy Medication Adherence |
NCT06244004 |
FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial |
NCT06378346 |
GU-01: Glycyrrhizin in Prostate Cancer |
NCT05534646 |
Study of Apalutamide With Carotuximab in Metastatic, Castration-Resistant Prostate Cancer |
NCT05309655 |
Cardiac Outcomes With Near-Complete Estrogen Deprivation |
NCT05056844 |
Contrast Enhanced Spectral Mammography for the Evaluation of Pathologic Nipple Discharge |
NCT03804944 |
Converting HR+ Breast Cancer Into an Individualized Vaccine |
NCT06533644 |
A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer |
NCT05864144 |
A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors |
NCT05912244 |
A Study of IO102/IO103, Nivolumab, and Relatlimab in People With Melanoma |
NCT04631744 |
Cabozantinib in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC) |
NCT05900895 |
Estradiol Plus Olaparib for Breast Cancer (PHOEBE) |
NCT06617481 |
PET Scan Study to Detect Prostate Cancer in Patients with Early PSA Recurrence |
NCT05365581 |
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer |
NCT05130255 |
GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2 |
NCT06340646 |
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS) |
NCT06067269 |
Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients with Prostate Cancer, HEATWAVE Trial |
NCT05413850 |
Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection |
NCT05616650 |
Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor |
NCT03311308 |
A Trial of Pembrolizumab and Metformin Versus Pembrolizumab Alone in Advanced Melanoma |
NCT06461650 |
Preoperative Nicotine Cessation for Women With Breast Cancer Recommended for Reconstruction |
NCT06332755 |
Study to Evaluate LB-LR1109 for the Treatment of Solid Tumors |
NCT04090567 |
Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer |
NCT04415944 |
Trial Evaluating Feasibility and Quality of Life of Second Look Laparoscopy With Hyperthermic Intraperitoneal Chemotherapy |
NCT06744465 |
NearWave Optical Molecular Monitoring |
NCT05305365 |
Study Assessing QBS72S For Treating Brain Metastases |
NCT05045066 |
Immunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer Patients |
NCT05800665 |
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer |
NCT05156866 |
First in Human Study of TORL-2-307-ADC in Participants With Advanced Cancer |
NCT05693766 |
Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort |
NCT02871726 |
Transrectal Ultrasound Robot-Assisted Prostate Biopsy |
NCT05391126 |
GENOCARE: a Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care |
NCT06533826 |
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd |
NCT05183126 |
Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer |
NCT04768426 |
Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer |
NCT06295965 |
Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study |
NCT04872166 |
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer |
NCT02610426 |
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer |
NCT06633926 |
Integrative Approaches for Cancer Survivorship (IACS3) |
NCT06420726 |
Resistance Exercise and Creatine in Colorectal Cancer |
NCT05696626 |
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation |
NCT05036226 |
COAST Therapy in Advanced Solid Tumors and Prostate Cancer |
NCT06568692 |
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer |
NCT06157892 |
A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors |
NCT05846789 |
SOC Chemotherapy +/- Tocilizumab for Triple Negative and ER-low Breast Cancers |
NCT03567889 |
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C Melanoma Patients |
NCT05896189 |
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors |
NCT06267729 |
Study of AZD0754 in Participants With Metastatic Prostate Cancer |
NCT05498792 |
Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma |
NCT03682289 |
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors |
NCT05376592 |
Assoc. of Genomic Polymorphisms With Cancer Cachexia in Subjects With Panc Adenocarcinoma |
NCT06566092 |
Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult Participants |
NCT02000089 |
The Cancer of the Pancreas Screening-5 CAPS5)Study |
NCT06481592 |
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer. |
NCT06171789 |
PRO1107 in Patients With Advanced Solid Tumors |
NCT04722692 |
Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ |
NCT06548789 |
Neoadjuvant Immune Checkpoint Blockade + a Prebiotic Food-enriched Dietary Intervention to Optimize Immune Response in Melanoma: NEO-PreFED |
NCT06401889 |
Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy |
NCT05086692 |
A Beta-only IL-2 ImmunoTherapY Study |
NCT06627244 |
Study of Tebentafusp and Radioembolization in the Treatment of Metastatic Uveal Melanoma |
NCT06990880 |
A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer |
NCT06767462 |
An Ophthalmic Safety Study in Patients With Breast Cancer |
NCT04588662 |
A Prospective Natural History Study in Uveal Melanoma |
NCT06635980 |
Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer |
NCT05458544 |
[Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application |
NCT05535192 |
TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients |
NCT05705492 |
Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer |
NCT05930496 |
Evaluating the Effects of an Exercise Intervention on the Gut Microbiota in Stage II-III Colorectal Cancer Survivors |
NCT05377996 |
A Study of XMT-1660 in Participants With Solid Tumors |
NCT06925724 |
A Study of Ivonescimab in People With Endometrial and Cervical Cancers |
NCT00034216 |
Collection of Blood From Patients With Cancer |
NCT06568016 |
A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal Immunochemical Test Result in Patients at Federally Qualified Health Centers |
NCT03354416 |
Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer |
NCT05125016 |
A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With Cemiplimab or REGN5678 for Adult Participants With Advanced Prostate Cancer |
NCT04975516 |
Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer |
NCT06551324 |
A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1). |
NCT06205316 |
SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma |
NCT06428396 |
Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029) |
NCT05981716 |
Young Breast Cancer Survivors Study |
NCT05914116 |
A Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors |
NCT03943316 |
Laboratory Study of Cancer & Immune Cells in Ascites Fluid of Ovarian Cancer Patients to Test Alternative Therapies |
NCT06826924 |
7-Days Water-Only Fasting Trial in Prostate Cancer |
NCT06492616 |
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence |
NCT03686124 |
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors |
NCT06084416 |
A Study of Sovilnesib in Subjects with Ovarian Cancer |
NCT05915442 |
Adenosine Signaling Modulation and Immune Checkpoint Inhibition With Hormone Sensitive Oligometastatic Prostate Cancer |
NCT04724499 |
Improving Cognitive Function Through High-intensity Interval Training in Breast Cancer Patients Undergoing Chemotherapy |
NCT04787042 |
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067 |
NCT06349642 |
Predicting Response to Immune Checkpoint Inhibitors Across Solid Tumors Using a Live Tumor Diagnostic Platform |
NCT04429542 |
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors |
NCT04174742 |
Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer |
NCT04169542 |
Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery |
NCT04270149 |
Cancer Peptides Plus GM-CSF and Adjuvant in Breast Cancer |
NCT04462406 |
Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial |
NCT04115306 |
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer |
NCT06526299 |
Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease |
NCT05595499 |
Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors |
NCT03484299 |
Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma |
NCT05898399 |
Study of ART6043 in Advanced/Metastatic Solid Tumors Patients |
NCT06190899 |
Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer |
NCT04945642 |
High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma |
NCT05751434 |
A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer |
NCT06067841 |
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer |
NCT05170334 |
Binimetinib Plus Belinostat for Subjects With Metastatic Uveal Melanoma |
NCT05565534 |
Diabetes Care for Breast Cancer Patients |
NCT06457919 |
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer |
NCT05683418 |
A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With Select Solid Tumors |
NCT05995236 |
Prostate-Specific Membrane Antigen (PSMA) Radionuclide Therapy |
NCT05168618 |
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial |
NCT06107413 |
Study to Assess Adverse Events and Change in Disease Activity in Previously Treated Adult Participants Receiving Intravenous (IV) ABBV-400 With Unresectable Metastatic Colorectal Cancer in Combination With IV Fluorouracil, Folinic Acid, and Bevacizumab |
NCT04081636 |
Prostate Biopsy, Transrectal vs. Transperineal: Efficacy and Complications |
NCT06112613 |
Mobile Health for Adherence in Breast Cancer Patients |
NCT01961713 |
Circulating Tumor Cell Analysis in Patients With Localized Prostate Cancer Undergoing Prostatectomy |
NCT05879913 |
ASCVD Management Using CCTA in Prostate Cancer Patients on ADT |
NCT04485013 |
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers |
NCT05223036 |
Testing Obeticholic Acid for Familial Adenomatous Polyposis |
NCT04511013 |
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases |
NCT06699836 |
A Phase 2 Study of Leronlimab in Combination With TAS-102 + Bevacizumab in Previously Treated Participants With mCRC |
NCT04599218 |
MR/TRUS Fusion Guided Prostate Biopsy - An Improved Way to Detect and Quantify Prostate Cancer |
NCT02610413 |
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Hypertension Receiving Bevacizumab for Breast Cancer |
NCT05977036 |
BettER: Biomarker Driven Early Therapeutic Selection in Patients With HR+ HER2- Metastatic or Unresectable Breast Cancer |
NCT05590949 |
Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors |
NCT05754749 |
Comparison of CE-DBT and MRI in Patients With Known Breast Lesions |
NCT04778449 |
Quality of Life, Lifestyle, and Psychosocial Factors in Patients With Melanoma |
NCT05193149 |
Inspiratory Muscle Training in Obese Breast Cancer Survivors |
NCT02838836 |
Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers |
NCT06252649 |
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation |
NCT06064149 |
The CArdiovascular Risk Evaluation in Men With Prostate Cancer Study (CARE-PC) Pilot Feasibility Study |
NCT06085313 |
Cancer Pain Management Using a Web-based Intervention |
NCT06785636 |
Open-Label Study of Pocenbrodib Alone and in Combination With Abiraterone Acetate, Olaparib, or 177Lu-PSMA-617 |
NCT06515613 |
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors |
NCT06153836 |
Neurotization of the Nipple Areolar Complex to Restore Sensation for Patients With Breast Cancer Undergoing Nipple Sparing Mastectomy and Reconstruction |
NCT05141149 |
First in Human Phase1/2a Clinical Trial of Anti-PAUF Monoclonal Antibody PBP1510 in Patients With Pancreatic Cancer |
NCT06831136 |
Endoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct Adenocarcinoma |
NCT03785249 |
Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1 |
NCT05805436 |
Preop Laxatives in Robotic Urologic Surgery |
NCT06205849 |
Intra-tumoral Mitazalimab (CD40 Antibody) With Irreversible Electroporation (IRE) in Locally Advanced Pancreas Cancer |
NCT06060613 |
Safety and Efficacy of OBX-115 in Advanced Solid Tumors |
NCT05035836 |
A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC) |
NCT05241236 |
MRI/Ultrasound Fusion Guided Laser Ablation of Prostate Cancer |
NCT06827613 |
A Study of Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab Govitecan in Participants With Advanced Solid Tumors |
NCT04349436 |
A Phase 1B/2 Study of RP1 in Solid Organ Transplant Patients With Advanced Cutaneous Malignancies |
NCT04114136 |
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies |
NCT04071236 |
Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal Therapy |
NCT05034536 |
PD-1 Antibody Therapy + Infliximab for Metastatic Melanoma |
NCT05054413 |
Formulating Expert Consensus Guidelines in Cancer Care Using the Delphi Method |
NCT06827236 |
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer |
NCT06619236 |
Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer |
NCT06205836 |
Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer |
NCT05790213 |
Prostate Cancer Treatment Using Androgen Deprivation Therapy and Focal Prostate Ablation |
NCT06199713 |
Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients |
NCT06723236 |
A Study of MGC028 in Participants With Advanced Solid Tumors |
NCT06801236 |
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer |
NCT06355336 |
Real World Prostate Cancer Registry |
NCT03096418 |
Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response |
NCT05141513 |
Intraoperative Radiation Therapy After Stereotactic Body Radiation Therapy and Chemotherapy in Treatment of Pancreatic Adenocarcinoma |
NCT03474913 |
Upright MRI for Prostate Cancer Screening |
NCT06961006 |
A Clinical Study of V940 and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012) |
NCT04333706 |
A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER) |
NCT04557449 |
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors |
NCT06637306 |
Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer |
NCT06105749 |
Biennial CEM in Women with a Personal History of Breast Cancer |
NCT02600949 |
Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer |
NCT06216249 |
Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT) |
NCT01913106 |
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer |
NCT06855706 |
An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 Study |
NCT05508906 |
Phase 1b Combo w/ Ribociclib, Alpelisib, or Everolimus |
NCT06305299 |
Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells |
NCT05703399 |
Long Term Followup of Patients Enrolled in MC1137, BEAUTY Study |
NCT06011499 |
Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVE |
NCT05520099 |
Observational Basket Trial to Collect Tissue to Train and Validate a Live Tumor Diagnostic Platform |
NCT05743049 |
Collection of Circulating Biomarkers in Pancreatic Cancer |
NCT06115499 |
The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer |
NCT05957042 |
Pilot Study to Evaluate if Contrast Enhanced Ultrasound (CEUS) Can Predict Treatment Response in Triple Negative Breast Cancer (TNBC) Patients Receiving Combined Chemotherapy and Immune Checkpoint Inhibitors (ICI). |
NCT02012699 |
Integrated Cancer Repository for Cancer Research |
NCT05029999 |
CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer |
NCT04971499 |
A Study of Dapansutrile Plus Pembrolizumab in Patients With PD-1 Refractory Advanced Melanoma |
NCT06444542 |
Understanding Patient Preference on Colorectal Cancer Screening Options-PSU |
NCT05382299 |
Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer |
NCT06880549 |
A Study of mRNA-4106 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Solid Tumors |
NCT05245006 |
PET Imaging Study of 89Zr-DFO-YS5 in Men With Prostate Cancer |
NCT06161506 |
Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer |
NCT05763199 |
Standardized Extract of Cultured Lentinula Edodes Mycelia (AHCC®) in Ovarian Cancer Patients on Adjuvant Chemotherapy |
NCT05014399 |
Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy |
NCT06157099 |
Atorvastatin for Preventing Disease Metastasis in Patients With Resected High-Risk Stage IIA, IIB, or IIIA Melanoma |
NCT06600906 |
Hyperpolarized 13C MRI to Predict Response in Pancreatic Cancer |
NCT07020806 |
[68Ga]Ga DOTA-5G as a Diagnostic Imaging Agent for Metastatic/Advanced Invasive Lobular Breast Cancer (LBC) |
NCT06228599 |
Molecular Profile-related Individualized Targeted Therapy in Resected Pancreatic Cancer With High-Risk of Cancer Recurrence |
NCT05877599 |
A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation |
NCT06391099 |
Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer |
NCT07029399 |
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors |
NCT05640999 |
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER |
NCT06006299 |
Investigating the Use of TaVNS to Treat Insomnia in Individuals with Breast Cancer (taVNS-insomnia-BC) |
NCT05271318 |
Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or Pembrolizumab (Phase 1a and 2) and Pegylated Liposomal Doxorubicin (Phase 1b) as Treatment for Ovarian Cancer. |
NCT04605913 |
Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC |
NCT06288113 |
Re-treatment With 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, RE-LuPSMA Trial |
NCT04997018 |
A Study of MRI-guided High-dose Radiation Therapy in Prostate Cancer |
NCT06105918 |
Radioligand Therapy After PSMA PET Guided External Beam Radiotherapy for Treating Post-Prostatectomy Patients with Biochemically Recurrent Prostate Cancer |
NCT06429813 |
Remotely Monitored Exercise Interventions in Patients with MCSPC Undergoing ADT (Prostate 006) |
NCT06800313 |
A Study of HLD-0915 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) |
NCT06303713 |
LuCarbo - a Study of 177Lu-PSMA-617 Plus Carboplatin in Metastatic Castrate-resistant Prostate Cancer |
NCT06904313 |
Ultralow Dose PET Imaging for PSMA Expression |
NCT04222413 |
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors |
NCT05624918 |
A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma |
NCT03968406 |
Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers |
NCT06395506 |
THRIVE Well Cancer FDTN/Exercise_Creatine Supplementation |
NCT05519449 |
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01) |
NCT04055649 |
ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer |
NCT06858449 |
Resistance Training and Post Workout Protein to Improve Body Composition During Neoadjuvant Chemotherapy for Breast Cancer |
NCT04567706 |
A Storage Facility for Tissues Obtained From Patients With Malignant Melanoma |
NCT05341349 |
Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-100M for the Treatment of Melanoma Brain Metastases |
NCT02598349 |
Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas |
NCT05241249 |
Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic Adenocarcinoma |
NCT06195306 |
Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction |
NCT06127979 |
A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before Surgery |
NCT04753879 |
Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer. |
NCT04933084 |
Pre-operative Education Modalities to Decrease Opioid Use |
NCT05527184 |
First in Human Study of IMGN151 in Recurrent Gynaecological Cancers |
NCT03998202 |
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer |
NCT06750484 |
Trial of Trastuzumab Deruxtecan in Previously Treated HER2 |
NCT06112379 |
A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer |
NCT06238479 |
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors |
NCT06728579 |
Enhanced Pain Coping in Cancer (EPIC): A Study of Managing Treatment-Related Joint Pain in Breast Cancer Survivors |
NCT01042379 |
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer |
NCT05755984 |
3D Printed Breast Models in the Surgical Management of Breast Cancer |
NCT04821284 |
Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer |
NCT04792684 |
Collection of Samples USOPTIVAL Study |
NCT04368702 |
CONFIRM: Magnetic Resonance Guided Radiation Therapy |
NCT06105021 |
Phase I Study of Autologous CD8+ and CD4+ Engineered T Cell Receptor T Cells in Subjects With Advanced or Metastatic Solid Tumor |
NCT06330064 |
A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02) |
NCT06101290 |
Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER) |
NCT05413421 |
Study of ORIC-944 in Patients with Metastatic Prostate Cancer |
NCT06943521 |
A Study of MT-4561 in Patients With Various Advanced Solid Tumors |
NCT06112990 |
Creatine Supplementation and Resistance Training to Preserve Muscle Mass and Attenuate Cancer Progression |
NCT06085664 |
A Pilot Presurgical Trial of REGN5678 (Anti-PSMA x CD28) in Patients With High-risk, Localized Prostate Cancer Followed by Radical Prostatectomy |
NCT04965064 |
Trial of Neratinib Plus Capecitabine in Subjects with HER2-Negative Metastatic Breast Cancer with Brain Metastases and Abnormally Active HER2 Signaling |
NCT01174121 |
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer |
NCT06401421 |
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD) |
NCT04698564 |
Utility of Hyperpolarized 13C-pyruvate Metabolic Magnetic Resonance Imaging |
NCT06661902 |
Buffered Lidocaine for Reducing Pain in Patients Undergoing Prostate Biopsy, BURN Trial |
NCT04469764 |
Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer |
NCT06272864 |
BostonGene and Exigent Genomic INsight Study |
NCT06518564 |
Avelumab and M1774 in ARID1A-mutated Endometrial Cancer (Prior IO) |
NCT06655064 |
Registry to Evaluate Long-Term Outcomes in Patients Who Undergo 68-Ga-PSMA-11 PET/CT Imaging Evaluations |
NCT05378464 |
Adoptive T Cell Therapy Following HER2-Pulsed Dendritic Cell Vaccine & Pepinemab /Trastuzumab in Patients w/ Metastatic HER2+ Breast Cancer |
NCT04968964 |
Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity Testing |
NCT04363164 |
Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression |
NCT06888921 |
A Clinical Trial to Evaluate the Safety and Efficacy of COM701 in Relapsed Platinum Sensitive Ovarian Cancer |
NCT04759664 |
LUT014 for the Reduction of Dose-Limiting Acneiform Lesions Associated With EGFRI Treatment of mCRC |
NCT05647564 |
PET/CT Characterization of Treatment Resistance |
NCT05826964 |
Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer |
NCT04354064 |
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors |
NCT06007690 |
A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma |
NCT06523803 |
A Study of ZW171 in Participants With Advanced or Metastatic Mesothelin-expressing Cancers |
NCT06179303 |
Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer |
NCT05005403 |
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) and Other Solid Tumors, Receiving Intravenous (IV) Infusion of Azirkitug (ABBV-514) Alone or in Combination With Budigalimab or Bevacizumab |
NCT01794403 |
Radiation Hypofractionation Via Extended Versus Accelerated Therapy (HEAT) for Prostate Cancer |
NCT05700903 |
Contributions to Hypertension With Androgen Deprivation Therapy |
NCT06705803 |
Prostate Ablation Registry and Database for Information, Surveillance, and Evaluation (PARADISE) |
NCT05381103 |
PSMA-PET to Guide Prostatectomy |
NCT06738303 |
Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer |
NCT06103864 |
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer |
NCT06144164 |
A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer |
NCT06833502 |
Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer |
NCT05650021 |
Rectal Spacer for Prostate Cancer Radiation Image Guidance |
NCT06706921 |
18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer |
NCT04373564 |
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years |
NCT05296421 |
Investigating Targetable Metabolic Pathways Sustaining Pancreatic Cancer |
NCT03833921 |
Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate Cancer |
NCT06824064 |
Evaluation of RBS2418 in Patients with Advanced, Metastatic, and Progressive Colorectal Cancer |
NCT06257264 |
A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors |
NCT06353321 |
Non-significant Risk (NSR) Study of [68Ga]-PSMA-11 (Illuccix) as a BgRT BioGuide on RefleXion X1 |
NCT06631521 |
Neoadjuvant Darolutamide and Relugolix Combination Preceding Radical Prostatectomy for Prostate Cancer |
NCT04990921 |
Study of Palliative Radiation Combined with Pembrolizumab in Unresectable Metastatic Stage IV Breast Cancer |
NCT06428721 |
The Preventive Role of Fractionated Laser Resurfacing Against Actinic Neoplasia in an At-Risk Geriatric Population |
NCT00923221 |
Collection of Blood From Patients With Prostate Cancer |
NCT06150664 |
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies |
NCT05786664 |
Breast Cancer Survivorship Biorepository |
NCT05683964 |
Androgen Receptor Signaling and Prostate-Specific Membrane Antigen Expression |
NCT05200364 |
A Study of STRO-002, an Anti-Folate Receptor Alpha Antibody Drug Conjugate, in Combination With Bevacizumab in Epithelial Ovarian Cancer |
NCT04521764 |
A Vaccine (MV-s-NAP) for the Treatment of Patients with Invasive Metastatic Breast Cancer |
NCT05743621 |
Study of TVB-2640 in Men With Metastatic Castration-Resistant Prostate Cancer |
NCT05423964 |
Impact of AI on Trainee ADR |
NCT04019964 |
Nivolumab in Biochemically Recurrent dMMR Prostate Cancer |
NCT05919264 |
FOG-001 in Locally Advanced or Metastatic Solid Tumors |
NCT05685602 |
CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic Cancer |
NCT04420702 |
Diffusion Basis Spectrum Imaging of the Prostate |
NCT06102902 |
Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer |
NCT05923684 |
NLP-Based Feedback to Improve Risk Comms and Informed Shared Decision Making |
NCT06036121 |
A Study of ADRX-0706 in Select Advanced Solid Tumors |
NCT05741164 |
Propranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast Cancer |
NCT06323421 |
Targeting Chronic Stress for Reducing Risk Factors for Colorectal Cancer |
NCT04038502 |
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer |
NCT04139902 |
Neoadjuvant PD-1 Inhibitor Dostarlimab (TSR-042) Vs. Combination of Tim-3 Inhibitor Cobolimab (TSR-022) and PD-1 Inhibitor Dostarlimab (TSR-042) in Melanoma |
NCT04897321 |
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) |
NCT04005690 |
Targeted Pathway Inhibition in Patients With Pancreatic Cancer |
NCT05949021 |
OCTANE: Adjuvant Liposomal Doxorubicin and Carboplatin for Early-stage Triple-negative Breast Cancer |
NCT06238921 |
Sacituzumab Govitecan and Zimberelimab w/SRS in the Management of Metastatic Triple Negative Breast Cancer With Brain Metastases |
NCT06284590 |
Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination with Pembrolizumab, in Unresectable Melanoma Patients |
NCT05950464 |
Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer |
NCT05559164 |
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted |
NCT04913064 |
Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast Cancer |
NCT06434064 |
Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer |
NCT04766190 |
DISCO: A Patient Intervention to Reduce the Financial Burden of Cancer |
NCT05128890 |
Evaluation of Resection Techniques for Pancreatic Tumors |
NCT06666790 |
DermaSensor Postmarket Surveillance Study |
NCT06956690 |
A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ENV-501 in Patients With HER3-Expressing Solid Tumors |
NCT06067503 |
Biomarkers to Detect Endocrine Therapy Resistance |
NCT05126290 |
CTNNA1 Familial Expansion Study |
NCT05689021 |
CJNJ-67652000 and Prednisone for Treatment of Metastatic Castration-Resistant Prostate Cancer and SPOP Gene Mutations |
NCT03054584 |
Genetic Basis of Melanocytic Nevi |
NCT06336902 |
Botensilimab Plus Balstilimab and Fasting Mimicking Diet Plus Vitamin C for Patients with KRAS-Mutant Metastatic Colorectal Cancer |
NCT03011684 |
Fertility Preservation Using Tamoxifen and Letrozole in Estrogen Sensitive Tumors Trial |
NCT05170802 |
Pancreatic Cancer & Surgical Resection |
NCT05935384 |
SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation |
NCT05398302 |
Image-Guided Biopsies to Identify Mechanisms of Resistance in Patients With Metastatic Castration Resistant Prostate Cancer Treated With 177Lu-PSMA Radioligand Therapy |
NCT05677802 |
Feasibility Study of Biobehavioral Stress Reduction Intervention in Patients With Triple Negative Breast Cancer |
NCT02621021 |
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab |
NCT06888102 |
A Platform Study of Epigenetic Therapy Before Prostatectomy in Men With Prostate Cancer |
NCT06321484 |
Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer |
NCT06105684 |
Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast Cancer |
NCT06580002 |
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial |
NCT05780684 |
Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer |
NCT04080284 |
Trial of Maintenance With Niraparib- Uterine Serous Carcinoma |
NCT02594202 |
Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue |
NCT04857502 |
99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer |
NCT06599502 |
A Phase I/IIa Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD0022 as Monotherapy and in Combination With Anti-cancer Agents in Adult Participants With Tumours Harbouring a KRASG12D Mutation |
NCT06535802 |
iCCaRE Consortium Pilot Project 1: Feasibility of a Point of Prostate Cancer Diagnosis Intervention for Newly Diagnosed Black Men |
NCT06873802 |
ZTE MRI Pulse Sequence Use for Visualization of Bone Cement, Breast Biopsy Markers |
NCT05926102 |
The Prostate Cancer, Genetic Risk, and Equitable Screening Study (ProGRESS) |
NCT05984602 |
A Phase IB Study to Determine the Safety and Tolerability of Canakinumab and Tislelizumab in Combination With Nab-Paclitaxel and Gemcitabine in the Neo-adjuvant Treatment of Patients With Pancreatic Cancer |
NCT07020221 |
A Phase 1/2a Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors |
NCT06047379 |
Safety and Efficacy of NEO212 in Patients with Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis |
NCT06439979 |
Rural Adult and Youth Sun Protection Study |
NCT04683679 |
A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer |
NCT06108479 |
Study of DF6215 in Patients with Advanced Solid Tumors |
NCT05559879 |
Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma |
NCT05524584 |
Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer |
NCT03941379 |
A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma |
NCT06237179 |
Behavioral Exercise Training to Reduce Cardiovascular Disease Risk |
NCT04986579 |
Scalp Cooling in MBC |
NCT06783179 |
Postoperative Outcomes and Patient Satisfaction With Mayo Clinic Florida Care Hotel After Mastectomy and Tissue Expander Placement |
NCT05507879 |
TRPC6 Characterization to Predict and Prevent Chemotherapy Related Cardiomyopathy and Heart Failure With Breast Cancer |
NCT05598879 |
Global Cardio Oncology Registry |
NCT04820179 |
Atezolizumab + Cabozantinib in Patients w/ Metastatic, Refractory Pancreatic Cancer |
NCT06629779 |
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer. |
NCT06691984 |
Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer |
NCT06831084 |
Acute Radiation Dermatitis After Adjuvant Radiotherapy for Breast Cancer Patients With the Use of Silver-Plated Technology |
NCT05134779 |
De-convoluting Interactions Between Genes, the Cancer Environment, and the Immune System to Develop Therapies That Work for You |
NCT06136884 |
A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors |
NCT06327490 |
A Study Evaluating the Feasibility and Compliance of Manual Lymphatic Drainage Comparing Indocyanine-Green (ICG) Guided vs. Traditional Guided in Patients Undergoing Axillary Node Dissection for the Treatment of Breast Cancer |
NCT02381990 |
MRI/Ultrasound Fusion Guided Prostate Cryotherapy |
NCT05675579 |
A Phase II Study of Neoadjuvant Sacituzumab Govitecan and Pembrolizumab Therapy for Immunochemotherapy-resistant Early-stage Triple-negative Breast Cancer (TNBC) |
NCT06528990 |
Telehealth Intervention for Ostomy Self-Management |
NCT05968690 |
Naltrexone and Propranolol Combined With Immunotherapy |
NCT05074290 |
Pharmacokinetics and Safety of Epidiferphane and Taxanes in Breast Cancer Patients |
NCT06441890 |
BRE-10: Biomarker Optimization of Neoadjuvant Therapy in Breast Cancer |
NCT06677190 |
Belzutifan in Recurrent Clear Cell Ovarian Carcinoma |
NCT06650579 |
REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial |
NCT06917079 |
BBO-11818 in Adult Subjects With KRAS Mutant Cancer |
NCT05870579 |
[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer |
NCT05050084 |
Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial |
NCT05419479 |
Switch Maintenance in Pancreatic |
NCT04762979 |
Alpelisib (BYL719) in Combination With Continued Endocrine Therapy Following Progression on Endocrine Therapy in Hormone Receptor Positive, HER2 Negative, PIK3CA Mutant Metastatic Breast Cancer |
NCT02945579 |
Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy |
NCT05633979 |
Phase 1b Study of EZH1/2 Inhibitor Valemetostat in Combination With Trastuzumab Deruxtecan in Subjects With HER2 Low/Ultra-low/Null Metastatic Breast Cancer |
NCT05373823 |
MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors |
NCT06400550 |
Identification of Metabolic Phenotypes Associated With Melanoma Metastasis |
NCT05055323 |
A Study to Determine if the Drug, Pyrvinium Pamoate, is Safe and Tolerable in Patients With Pancreatic Cancer |
NCT06215508 |
Geriatric Assessment and Technology Evaluation in Prostate Cancer |
NCT03424850 |
Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy |
NCT06733350 |
Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance |
NCT06184750 |
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial |
NCT06151223 |
A Prospective Registry for Patients at High-Risk for Pancreatic Cancer |
NCT06966050 |
Multi-center MRD Registry for Inflammatory Breast Cancer |
NCT05471414 |
Whole-Food Plant-Based Diet to Control Weight and MetaboInflammation in Overweight/Obese Men With Prostate Cancer |
NCT06014255 |
Trial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate Cancer |
NCT05676255 |
The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project |
NCT04379414 |
YES Study - Newly Diagnosed/Metastatic Intervention |
NCT04839614 |
Concurrent Laparoscopic Hysterectomy and Weight Loss Surgery in Obese Patients With Endometrial Carcinoma or Endometrial Intraepithelial Neoplasia |
NCT03987555 |
Paclitaxel Therapeutic Drug Monitoring in Cancer Patients |
NCT05806814 |
Sipuleucel-T Based Autologous Cellular Immunotherapy for Advanced Prostate Cancer |
NCT05780814 |
The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer |
NCT04049214 |
Perioperative Mindfulness Proposal |
NCT06504914 |
Preparing FIM-BCS - A Lifestyle Modification for African-American Breast Cancer Survivors |
NCT05301114 |
Social Risk Factors and Discrimination in Cancer Survivorship |
NCT06054555 |
A Study to Evaluate ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Unresectable or Metastatic Melanoma |
NCT06961955 |
5 vs. 9-day Course of Whole Breast Radiotherapy With Boost for Early-stage Breast Cancer |
NCT05715255 |
Adaptive Symptom Self-Management Immunotherapy Study |
NCT06016855 |
Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors |
NCT06529523 |
Tislelizumab in People With Colorectal Cancer |
NCT05483023 |
18-fluorofuranylnorprogesterone (FFNP) PET/MRI as a Potential Biomarker of Response to Progesterone Therapy |
NCT04396808 |
Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate Cancer |
NCT00001823 |
Evaluation for NCI Surgery Branch Clinical Research Protocols |
NCT03979508 |
Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer |
NCT05687123 |
Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors |
NCT02313623 |
MR-US Image Fusion Targeted Biopsy for Single-cell Prostate Cancer Research |
NCT06617923 |
Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer |
NCT04915508 |
Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy |
NCT05779423 |
Cryoablation+Ipilimumab+Nivolumab in Melanoma |
NCT03334708 |
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma |
NCT06981208 |
ChatGPT & Surgeon Synergy: Redefining Breast Reconstruction Consultations for Enhanced Patient Engagement and Satisfaction |
NCT04088708 |
Gut Microbe Composition, Exercise, and Breast Breast Cancer Survivors |
NCT05732623 |
Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer |
NCT06636123 |
GZ17-6.02 in Advanced CRPC After Progression on Anti-Androgen Therapy |
NCT01416714 |
Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy |
NCT06451614 |
SpaceIT Hydrogel System for Perirectal Spacing |
NCT04729114 |
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer |
NCT05939414 |
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC. |
NCT06544655 |
A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors |
NCT06220214 |
Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer |
NCT05530655 |
A Study to Determine the Preferred Dose of the Drug, Lisinopril, for Preventing Urinary Toxicity Following Radiotherapy for Prostate Cancer |
NCT06483555 |
Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel |
NCT06943755 |
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors |
NCT04606914 |
Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy with Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer |
NCT05053555 |
High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies |
NCT06112314 |
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301) |
NCT06833255 |
A Post-treatment Supportive Service Program for the Transition Into Survivorship for Black Women Breast Cancer Survivors in Western New York |
NCT04273555 |
Monitoring Early Response to Targeted Therapy in Stage IV HER2+ Breast Cancer Patients with Advanced PET/MR Imaging |
NCT05819255 |
TRAQinform Assessment of Immunotherapy Response |
NCT06006923 |
Regorafenib in Combination With Pembrolizumab or Pembrolizumab for MSI-H Colorectal Cancer |
NCT05871008 |
Integrated Actionable Aging Assessment for Cancer Patients Pilot |
NCT06534008 |
Strive Cardio for Endometrial Cancer Survivors |
NCT06096623 |
The Care Tracker Study: Using Patient-Reported Data to Address Racial Disparity in Cancer Treatment |
NCT05386108 |
Study of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to ER+/HER-2- Breast Cancer |
NCT05512208 |
A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib |
NCT04899908 |
Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases |
NCT03137095 |
Effects of Chemotherapy on Cognitive Function in Breast Cancer Patients & Non-Cancer Control Subjects With Optional Sub-Study Research Brain MRI |
NCT03322995 |
Pancreatic Cancer Adaptive Neoadjuvant Chemotherapy Trial |
NCT06745895 |
Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening |
NCT06411795 |
Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy |
NCT06484595 |
Clinical Trial Navigation to Increase Participation and Diversity in Cancer Clinical Trials |
NCT00005095 |
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention |
NCT03699995 |
MoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for Melanoma |
NCT06067295 |
Longitudinal Advanced Prostate Cancer Cohort (LAPCC) |
NCT06673095 |
Narrow Excision Versus Wide Excision for the Treatment of Adults With Invasive Cutaneous Melanoma, ICEMAN Trial |
NCT05435495 |
Mechanisms of Resistance to PSMA Radioligand Therapy |
NCT05379595 |
A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer |
NCT04585750 |
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) |
NCT05086250 |
Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic Cancer |
NCT06470750 |
Feasibility of Patient-Centered Home Care (PCHC) to Reduce Disparities in High-Risk Black Men (BM) with Advanced Prostate Cancer (CaP) |
NCT04291755 |
Development and Analysis of a Stool Bank for Cancer Patients |
NCT06494150 |
Nab-Sirolimus and Endocrine Therapy in Recurrent Low Grade Serous Ovarian Cancer (NARETO) |
NCT06730750 |
A Study of BMS-986490 With or Without Bevacizumab in Advanced Solid Tumors |
NCT05974150 |
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring |
NCT06136650 |
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004) |
NCT06512350 |
Identifying Patterns in the Breath of Individuals With Breast Cancer |
NCT06682650 |
Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics) |
NCT06049355 |
EMBRACE: Exercising Together |
NCT05013255 |
Pioglitazone Therapy Targeting Fatigue in Breast Cancer |
NCT06422455 |
Access to Genetic Testing in Underserved Patients With Cancer |
NCT06938555 |
The RolE of Prolonged Nightly faSTing to Improve Sleep and cOgnition in bREast Cancer Survivors |
NCT05841355 |
MADRE (Mammograms Available Due to Research and Education) |
NCT06247995 |
A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor. |
NCT07042581 |
A Study of Revaree Plus in People With Breast Cancer |
NCT06130995 |
Relugolix + Enzalutamide Study in High-Risk Prostate Cancer |
NCT05607095 |
A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, or Dedifferentiated Liposarcoma |
NCT05219695 |
Medical Imaging and Thermal Treatment for Breast Tumors Using Harmonic Motion Imaging (HMI) |
NCT05933395 |
Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor |
NCT06072781 |
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer |
NCT06302595 |
MRI Guided Prostate Biopsy |
NCT06084481 |
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400 |
NCT05452681 |
Piloting Y-AMBIENT: A Quality of Life Intervention for Young African American Breast Cancer Survivors |
NCT06469281 |
A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers |
NCT06149481 |
Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC) |
NCT06690281 |
A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal Malignancies |
NCT06772181 |
A Digital Health Intervention to Improve Symptoms and Physical Activity During Breast Radiation |
NCT06500481 |
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial |
NCT01503190 |
The Immune System's Response to Young Women's Breast Cancer |
NCT06349590 |
Manipulation of the Gut Microbiome by a Standardized Preoperative Diet to Prevent Colorectal Cancer Recurrence and Metastasis Following Surgery |
NCT06409390 |
Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer |
NCT05573555 |
TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study B) |
NCT05911243 |
Feasibility of Auricular Acupressure for Appetite and Weight in Patients With Stage II-IV Gastric, Esophageal, and Pancreatic Cancer |
NCT03842943 |
Neoadjuvant Combination Immunotherapy for Stage III Melanoma |
NCT05239338 |
Preserving Fertility After Colorectal Cancer Study |
NCT06562543 |
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer |
NCT06686043 |
HPV Vaccine, Imiquimod, and Metformin Combination Trial |
NCT05682443 |
ONC-392 Plus Lutetium Lu 177 Vipivotide Tetraxetan in Patients With mCRPC |
NCT05665738 |
Two-fraction HDR Monotherapy for Localized Prostate Cancer |
NCT05518903 |
Investigational Scan (68Ga-FAPI-46 PET/CT) for Imaging of Cancer-Associated Fibroblasts for Localized Pancreatic Ductal Adenocarcinoma |
NCT05826743 |
Safety and Effectiveness Evaluation of the COLO-BT as an Alternative Treatment to the Ileostomy |
NCT05972343 |
COOL-IT-PRO: Cryoablation of Breast Cancer in Non-surgical Patients |
NCT06187103 |
Evaluation of Improved Onboard Patient Imaging |
NCT05429203 |
Comparison of Duodenoscope With Single-use Distal Cover and the Conventional Reusable Duodenoscope |
NCT06270043 |
Focal Therapy for Localized Prostate Cancer |
NCT03456843 |
Therapeutic Effect of Cytoreductive Radical Prostatectomy in Men With Newly Diagnosed Metastatic Prostate Cancer |
NCT04472338 |
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study |
NCT05663203 |
A Web-Based Dyadic Intervention for Colorectal Cancer |
NCT02393703 |
Interrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic Cancer |
NCT04863443 |
Nonlinear Elasticity Mapping of Breast Masses |
NCT04725903 |
Proton Radiation Therapy for the Treatment of Patients with High Risk Prostate Cancer |
NCT06580743 |
Efficacy Verification in Early Diagnosis and Management of Lymphedema Through Home Body Water Analyzer |
NCT06675643 |
Digital Remote Monitoring of Immune Checkpoint Inhibitor Therapy Induced Toxicity: A Feasibility Study of the Vigilant App (Vigilant-2) |
NCT04658303 |
Evolution of Metabolic and Immune Dysfunction in In-transit Melanoma |
NCT04477343 |
A Study to Evaluate the Safety and Tolerability of SX-682 in Combination With Nivolumab as a Maintenance Therapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma |
NCT02276443 |
Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative |
NCT06200103 |
Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer |
NCT04907643 |
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes |
NCT06470243 |
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body |
NCT04705038 |
Effect of Education on Treatment Decision Making for Patients With Prostate Cancer on Chronic Hormone Treatments |
NCT05049538 |
Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers |
NCT04489238 |
Collection of Information to Better Understand Young Onset Colorectal Cancer |
NCT06336538 |
Abbreviated MBCT for Depression in Older African American/Black Breast Cancer Survivors |
NCT04517838 |
Immune Response to Anti-HER2 Therapies in Patients With HER2-Positive Stage I-IV Breast Cancer |
NCT06328738 |
ELVN-002 with Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer |
NCT06016738 |
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer |
NCT05069038 |
Clinical Trial Assessing the Safety of Neoadjuvant Palbociclib in Combination With Endocrine Therapy |
NCT05327608 |
Neoadjuvant Breast Cancer Time Restricted Eating |
NCT05505643 |
Cryoablation vs Lumpectomy in T1 Breast Cancers |
NCT06216938 |
RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node Metastasis |
NCT05534438 |
A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer |
NCT05919108 |
Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers |
NCT06153238 |
A PK Study to Compare GME751 (Proposed Pembrolizumab Biosimilar) and US-licensed and EU-authorized Keytruda® in Participants With Stage II and III Melanoma |
NCT04541108 |
Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies |
NCT06263543 |
Sequencing Antibody Drug Conjugates in ER+/HER2 LOW MBC |
NCT04003038 |
Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery |
NCT06831838 |
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors |
NCT02775643 |
Molecular Analysis of Childhood and Adolescent Melanocytic Lesions |
NCT05030038 |
Oral Aromatase Inhibitors Modify the Gut Microbiome |
NCT06084338 |
Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc |
NCT05417308 |
Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer |
NCT05720338 |
Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy? |
NCT05592938 |
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE) |
NCT03449238 |
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients |
NCT01607008 |
MRI for Assessing Prostate Cancer Response |
NCT06066138 |
A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing |
NCT06864338 |
Pilot Study for Colorectal Cancer and Advanced Adenoma Detection With the Mainz Biomed Colorectal Cancer Test |
NCT06228768 |
Acupressure for Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Patients With Breast Cancer |
NCT06408168 |
Phase II Study of REPotrectinib With or Without Fulvestrant in Patients With Hormone Receptor-positive Human Epidermal Growth Factor 2-negative Metastatic Invasive LObular Carcinoma Who Received a Prior Endocrine Therapy in Combination With Cyclin-dependent Kinase 4 and 6 Inhibitor (REPLOT Trial) |
NCT05892068 |
A Study of Tucatinib Given Before Surgery to People With HER2+ Cancers That Have Spread to the Brain |
NCT06362369 |
A Study of Oral 7HP349 (Alintegimod) in Combination with Ipilimumab Followed by Nivolumab Monotherapy |
NCT06865768 |
An Investigational Scan (18F-rhPSMA-7.3 PET-mpMRI) for Targeted Prostate Biopsy Using TRUS-MR Fusion Technique |
NCT06027268 |
Phase II Trial of Trilaciclib, Pembrolizumab, Gemcitabine and Carboplatin in Metastatic Triple-Negative Breast Cancer |
NCT04891068 |
BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer |
NCT01365169 |
Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients" |
NCT04644068 |
Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies |
NCT05113368 |
Regorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer |
NCT03460769 |
Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT) |
NCT05797168 |
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors |
NCT03050268 |
Familial Investigations of Childhood Cancer Predisposition |
NCT05581004 |
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors |
NCT04668872 |
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation |
NCT02333604 |
Cancer Experience Registry (CER) for Cancer Patients and Caregivers |
NCT05352672 |
Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma |
NCT05501704 |
ETHAN - ET for Male BC |
NCT05924672 |
Efficacy of Ra-223 in PSMA PET Optimally Selected Patients |
NCT06394804 |
A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian Cancer |
NCT05094804 |
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents |
NCT05964504 |
Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry) |
NCT02021604 |
Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma |
NCT01492972 |
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer |
NCT04576104 |
Megestrol Acetate Compared With Megestrol Acetate and Metformin to Prevent Endometrial Cancer |
NCT06215469 |
Portable Scalp Cooling System (PSCS) to Prevent Hair Loss for Breast Cancer Patients (Cooler Heads) |
NCT05318469 |
Ivermectin and Balstilimab for the Treatment of Metastatic Triple Negative Breast Cancer |
NCT06844669 |
HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy |
NCT05546268 |
Study of Oral MRT-2359 in Selected Cancer Patients |
NCT06989112 |
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer |
NCT04606446 |
Study of PF-07248144 in Advanced or Metastatic Solid Tumors |
NCT06678269 |
A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer |
NCT06444269 |
Precision Medicine in Action: Phase II Trial of Response Adaptive Ablative Pre-operative SPBI (RAPS) and Non-operative Sentinel Lymph Node Biopsy in Patients With Early-stage ER+ Breast Cancer: RAPS Trial |
NCT01050504 |
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer |
NCT06342401 |
Early Onset Colorectal Cancer Detection |
NCT00899301 |
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer |
NCT05727904 |
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma. |
NCT06129604 |
Pilot Window of Opportunity Trial (POET) |
NCT06745804 |
Study of 68Ga-R10602 |
NCT06605404 |
Pan-tumor MRD Study |
NCT06397703 |
ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer |
NCT06682390 |
Role of Race in Nutritional Approach in Men on ADT |
NCT05223803 |
TERPS Trial for De Novo Oligometastic Prostate Cancer |
NCT04916990 |
Improving Care for Rural Patients With Solid Tumors |
NCT05077137 |
A Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy |
NCT06760637 |
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease |
NCT05071937 |
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer |
NCT06538337 |
Hypofractionated External Beam Radiotherapy With Adaptive Planning for Endometrial and Cervical Cancers |
NCT04929223 |
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC) |
NCT06234423 |
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors |
NCT05447923 |
Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities |
NCT06782555 |
A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab |
NCT06500455 |
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain |
NCT06315595 |
Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion and Non-Contrast MRI |
NCT06051695 |
A Study to Evaluate the Safety and Efficacy of A2B694, a Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression |
NCT04624555 |
The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer Survivors |
NCT05837455 |
NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positive, HER2-negative Breast Cancer |
NCT04486755 |
Hypofractionated Accelerated Pelvic Nodal Radiotherapy (GCC 2048) |
NCT05280314 |
Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors |
NCT06392295 |
PSMA-Directed Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer |
NCT03513614 |
Tailored Axillary Surgery With or Without Axillary Lymph Node Dissection Followed by Radiotherapy in Patients With Clinically Node-positive Breast Cancer (TAXIS) |
NCT06643455 |
Mindfulness Intervention for Improving Nutrition in the Digital Kitchen Among Stage I-III Breast Cancer Survivors, MIND Trial |
NCT04775355 |
Study to Detect Changes in Urinary and Gut Microbiome During Androgen Deprivation Therapy and Radiation Therapy in Patients With Prostate Cancer |
NCT04144023 |
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ |
NCT06168812 |
A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer |
NCT06036810 |
Spanish Decision Tool for Ovarian Cancer Maintenance Therapy |
NCT06074510 |
PYLARIFY® PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate Cancer |
NCT06677112 |
MCC-24-GYN-11: Comparison of Nodal Sampling in Endometrial Cancer |
NCT06787612 |
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer |
NCT05839912 |
Excision of Lymph Node Trial (EXCILYNT) (Mel69) |
NCT05138510 |
Sexual Health in Breast Cancer Patients |
NCT06749210 |
DAANCE FOR CHEMOTHERAPY-INDUCED NEUROPATHY |
NCT04812912 |
Changes in Reproductive and Sexual Health in People With Early Onset Colorectal Cancer |
NCT03285412 |
CDK 4/6 Inhibitor, Ribociclib, With Adjuvant Endocrine Therapy for ER-positive Breast Cancer |
NCT06070012 |
Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma |
NCT05739981 |
Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer |
NCT03067181 |
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors |
NCT06185738 |
WeCanManage. An mHealth Self-management Tool |
NCT05806138 |
A Study of Vericiguat in People With Breast Cancer and Cancer Therapy-Related Cardiac Dysfunction |
NCT06476808 |
A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors. |
NCT05692323 |
A Supervised Prehabilitation Program for Patients With Pancreatic Cancer |
NCT05568550 |
Pembro With Radiation With or Without Olaparib |
NCT04765150 |
Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification |
NCT04348123 |
Interventional Program Educates, Identifies + Overcomes Barriers to Complete Screening Mammography |
NCT06058650 |
Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities |
NCT05477823 |
Imaging and Genomic Biomarkers to Predict Response in Prostate Cancer |
NCT04996823 |
Axitinib + Ipilimumab in Advanced Melanoma |
NCT04986423 |
ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer |
NCT04645810 |
A Study of Focal Salvage High-Dose-Rate Brachytherapy for Prostate Gland Only Recurrence |
NCT05396612 |
Role of the Immune Environment in Response to Therapy in Breast Cancer |
NCT02735746 |
Novel Lung Imaging in Adults Undergoing Radiation Therapy to Assess for Radiation Pneumonitis |
NCT06325046 |
Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer |
NCT05369546 |
Lesion Composition and Quantitative Imaging Analysis on Breast Cancer Diagnosis |
NCT06907446 |
Comparison of New SUREcore Biopsy of Needle to Standard of Care During Transperineal Prostate Biopsies |
NCT05396846 |
My Best GI Eating Study |
NCT05239546 |
Single Arm Study of Neoadjuvant Dostarlimab in Stage II and III Deficient Mismatch Repair Colon Cancers |
NCT05080946 |
Using Aspirin to Improve Immunological Features of Ovarian Tumors |
NCT06305312 |
Community Services Navigation to Advance Health Equity in Breast Cancer Screening |
NCT06079346 |
A Study of OT-101 With mFOLFIRINOX in Patients With Advanced and Unresectable or Metastatic Pancreatic Cancer |
NCT05043012 |
Diagnostic Performance Of Non-Endorectal Coil Multiparametric Magnetic Resonance Imaging Of Prostate With Flexible AIR Coil (DoNEMAC Study) |
NCT06850623 |
Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer |
NCT05827614 |
Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), in Subjects With Tumors With Oncogene Amplifications |
NCT05286814 |
PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma |
NCT06524895 |
Reiki Breast Surgery QOL Project for Women Undergoing Breast Surgery |
NCT06617455 |
Fezolinetant for the Improvement of Vasomotor Symptoms in Breast Cancer Patients Taking Endocrine Therapy, VENT Trial |
NCT06409195 |
A Trial to Study the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratoses and Non-Melanoma Skin Cancers |
NCT05863195 |
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial |
NCT06616155 |
Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer |
NCT06659614 |
Prostate Tissue BioBank |
NCT05014295 |
Patient Recall of Cancer Screening and Diagnosis |
NCT06055881 |
Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic Therapy |
NCT06580314 |
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer |